Form 4: Inari Medical Principal Accounting Officer Karen Silva Reports Acquisition by Stryker, Receives $80 Per Share

Karen Silva, Principal Accounting Officer of Inari Medical, reports the acquisition of Inari Medical by Stryker Corporation, resulting in the cancellation of her common stock and restricted stock units in exchange for $80 per share.

Summary

• On February 19, 2025, Inari Medical, Inc. was acquired by Stryker Corporation through a merger.
• Karen Silva, Principal Accounting Officer, reported the transaction on a Form 4 filing with the SEC.
• Each share of Inari Medical common stock was converted into the right to receive $80 in cash.
• Silva's restricted stock units (RSUs) were also canceled and converted into the right to receive cash based on the merger consideration.
• The merger was executed under the Agreement and Plan of Merger dated January 6, 2025.
• Following the merger, Inari Medical became a wholly-owned subsidiary of Stryker Corporation.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as the merger provides a clear exit strategy for shareholders at a defined price. The completion of the merger removes uncertainty.

Positives

• Shareholders of Inari Medical received $80 per share in cash as a result of the acquisition.

Future Outlook

Following the merger, Inari Medical operates as a wholly-owned subsidiary of Stryker Corporation.

Industry Context

This acquisition reflects a trend of consolidation in the medical device industry, where larger companies acquire smaller, innovative firms to expand their product portfolios and market reach.

Comparison to Industry Standards

• Acquisition valuations in the medical device industry vary widely based on factors such as growth rate, profitability, and intellectual property.
• Comparable acquisitions in the medical device space include [hypothetical example] Boston Scientific's acquisition of a smaller vascular device company for a similar multiple of revenue.
• The $80 per share valuation would need to be compared against industry averages for similar companies to determine if it was a favorable outcome for Inari Medical shareholders.

Stakeholder Impact

• Shareholders received $80 per share.
• Employees of Inari Medical now work for a subsidiary of Stryker Corporation, which may bring changes in organizational structure and benefits.
• The acquisition could lead to integration of Inari Medical's products into Stryker's broader portfolio, potentially impacting customers and suppliers.

Key Dates

Keywords

Inari Medical, Stryker Corporation, Merger, Acquisition, Karen Silva, Form 4, SEC, Principal Accounting Officer, Common Stock, Restricted Stock Units, NARI